尼達(dá)尼布Nintedanib (BIBF 1120) 是一種有效的三重血管激酶抑制劑,抑制 VEGFR1/2/3,F(xiàn)GFR1/2/3 和 PDGFRα/β 的 IC50 值分別為 34 nM/13 nM/13 nM,69 nM/37 nM/108 nM 和 59 nM/65 nM。
Inchi
InChI=1/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38)/b29-28-
物化屬性:
密度:1.284
沸點(diǎn):742.199°C at 760 mmHg
折射率:1.658
閃光點(diǎn):402.667°C
PSA:94.22000
LOGP:3.70270
參考文獻(xiàn)
[1]. Hilberg F, et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res, 2008, 68(12), 4774-4782.
[2]. Roth GJ, et al. Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120). J Med Chem, 2009, 52(14), 4466-4480.